Calithera Completes Patient Enrollment in Randomized Phase 2 Trial in Renal Cell Carcinoma February 4, 2019
PTC Therapeutics Launches New Program to Support Research Projects in Rare, Genetic Disorders January 31, 2019
ArcherDX’s Companion Diagnostic Assay for both Liquid Biopsy and Tissue Specimens Granted Breakthrough Device Designation by FDA January 8, 2019
